Advertisement
Journal Home
Search for

Volume 199, Issue 4, Pages 542-548 (April 2010)


View previous. 17 of 33 View next.

Cyclosporine A–protection against microvascular hyperpermeability is calcineurin independent

Ed W. Childs, M.D.aCorresponding Author Informationemail address, Binu Tharakan, Ph.D.a, Suliat Nurudeen, B.S.a, Thomas L. Delmas, B.S.a, Joseph Hellman, B.S.a, Tasheika Christie, B.S.b, Felicia A. Hunter, B.S.a, W. Roy Smythe, M.D.a

Received 1 July 2009; received in revised form 20 November 2009

Abstract 

Background

Mitochondria-mediated apoptotic signaling contributes to microvascular hyperpermeability. We hypothesized that cyclosporine A (CsA), which protects mitochondrial transition pores, would attenuate hyperpermeability independent of its calcineurin inhibitory property.

Methods

Hyperpermeability was induced in microvascular endothelial cell monolayers using proapoptotic BAK or active caspase-3 after CsA or a specific calcineurin inhibitor, calcineurin autoinhibitory peptide (CIP), treatment. Permeability was measured based on fluorescein isothiocyanate–albumin flux across the monolayers. Mitochondrial transmembrane potential (MTP) was determined using 5,5′,6,6′-tetrachoro-1,1′,3,3′-tetraethylbenzimidazolyl carbocyanine iodide. Mitochondrial release of cytochrome c was measured using an enzyme-linked immunosorbent assay and caspase-3 activity fluorometrically.

Results

CsA-attenuated (10 nmol/L) but not CIP-attenuated (100 μmol/L) BAK induced hyperpermeability (P < .05), CsA- but not CIP-attenuated BAK induced a decrease in MTP and an increase in cytochrome c levels and caspase-3 activity (P < .05). CsA and CIP were ineffective against caspase-3–induced hyperpermeability.

Conclusions

CsA attenuated hyperpermeability by protecting MTP, thus preventing mitochondria-mediated apoptotic signaling. The protective effect of CsA is independent of calcineurin inhibition.

a Department of Surgery, Texas A&M Health Science Center College of Medicine and Scott & White Memorial Hospital, 2401 South 31st St., Temple, TX 76508, USA

b Undergraduate Medical Academy, Prairie View A&M University, Prairie View, TX, USA

Corresponding Author InformationCorresponding author. Tel.: +1-254-724-5638; fax: +1-254-724-7912

PII: S0002-9610(09)00760-0

doi:10.1016/j.amjsurg.2009.11.002


View previous. 17 of 33 View next.

Advertisement